Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$25.86 - $46.71 $9,490 - $17,142
367 Added 12.96%
3,199 $148,000
Q4 2022

Feb 13, 2023

BUY
$19.77 - $42.23 $13,898 - $29,687
703 Added 33.02%
2,832 $88,000
Q2 2022

Aug 12, 2022

BUY
$13.19 - $22.1 $13,889 - $23,271
1,053 Added 97.86%
2,129 $33,000
Q4 2021

Feb 11, 2022

BUY
$22.41 - $37.54 $24,113 - $40,393
1,076 New
1,076 $27,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.